PHA-ICC, ADCC and NK in patients with ANLL in CR: Human fibroblastic interferon fails to increase NK-active cell frequency
- 1 January 1984
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 8 (5) , 885-891
- https://doi.org/10.1016/0145-2126(84)90109-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Normalized natural killer (NK) cell activity in long‐term remission of acute leukaemiaBritish Journal of Haematology, 1983
- Enhanced binding and functional activity of human natural killer cells after interferon treatmentClinical Immunology and Immunopathology, 1982
- Recycling and target binding capacity of human natural killer cells.The Journal of Experimental Medicine, 1981
- In vitro enhancement of natural and antibody-dependent lymphocyte-mediated cytotoxicity against tumor target cells by interferonCellular Immunology, 1979
- Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicityNature, 1979
- Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivoNature, 1977
- Purification, Fractionation and Assay of Antibody‐Dependent Lymphocytic Effector Cells (K Cells) in Human BloodScandinavian Journal of Immunology, 1976
- Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non‐immunized semi‐syngeneic mice against a mouse lymphoma lineInternational Journal of Cancer, 1975
- Ultrastructure of Lymphocyte-Mediated Cytotoxicity.British Journal of Haematology, 1975
- Lymphocyte cytotoxicity reactions to leukemia‐associated antigens in identical twinsInternational Journal of Cancer, 1972